Dozens of antacid brands, including Johnson & Johnson's trio of Rolaids, Pepcid and Mylanta, aren't available in the US due to recalls. As J&J works to get its products up to FDA muster and back on shelves, the pressure's on generic store brands such as Kroger’s and CVS private-label products to meet demand.

At a CVS store in Fortville, Ind., USA Today spotted a sign on a shelf where Pepcid AC should have been: "Looking for Pepcid AC products? Try CVS/pharmacy Brand for the same great results."

Less reputable outlets are looking to meet demand — witness the recent theft of $500 of heartburn products (either for personal or black market use) from Target.Continue reading...

Apple, hot on the heels of iPad 2 launch, tops Fortune's Most Admired Companies list for fourth year in a row.

Best Buy and other big box retailers rethink as they shrink.

Budweiser posts first global increase in two decades thanks to World Cup.

Charlie Sheen hits 1 million Twitter followers in less than a day.

Facebook growth slows in the US.

Ford issues recall, plans to harness its design gurus to relaunch the Mustang.

GM leads incentive spending as "Old GM" expected to be liquidated today.Continue reading...